I-Avantor® yokuFumana i-Ritter GmbH kunye neNdibaniselwano yayo;Yandisa uMnikelo woBunini boDidiagnostic kunye neDrug Discovery Workflows

I-RADNOR, Pa. kunye ne-SCHWABMÜNCHEN, eJamani, ngo-Epreli 12, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), umboneleli okhokelayo wehlabathi weemveliso ezibaluleke kakhulu kunye neenkonzo kubathengi kwiisayensi zobomi kunye nobuchwepheshe obuphambili kunye nokusebenza Imizi-mveliso yemathiriyeli, ebhengezwe namhlanje ukuba ingene kwisivumelwano esiqinisekileyo sokufumana i-Ritter GmbH yabucala kunye namahlakani ayo kwintengiselwano yemali yonke kunye nexabiso elithengiweyo elimalunga ne-890 yezigidi zeerandi ngokuxhomekeke kuhlengahlengiso lokugqibela ekuvaleni kunye neentlawulo ezongezelelweyo ezisekelwe ukuphumeza imigama ephambili yokusebenza kweshishini kwixesha elizayo.

Ikomkhulu e-Schwabmünchen, eJamani, i-Ritter ngumvelisi okhula ngokukhawuleza we-robotic ephezulu kunye ne-liquid handling consumables, kubandakanywa iingcebiso zokuqhuba ezenzelwe imigangatho echanekileyo.Ezi zinto zisetyenziselwa ukuvavanya i-molecular screening kunye nezicelo zokuxilonga, kubandakanya i-polymerase chain reaction (PCR) yexesha langempela, i-non-molecular assays ezifana ne-immunoassays, i-high-throughput high-throughput in vitro diagnostics (IVD) iteknoloji kuquka isizukulwana esilandelayo. ukulandelelana, kwaye njengenxalenye yokufunyanwa kweziyobisi kunye novavanyo lovavanyo lwezonyango kwi-pharma kunye ne-biotech applications.Xa zizonke, ezi zicelo zimele malunga ne-7 yeebhiliyoni zeerandi ezinokulungiseka kwimarike enamandla okukhula kwexesha elide.

Umgangatho ophezulu wokwenziwa kwemveliso kaRitter ubandakanya i-40,000 yeemitha zesikweri sendawo ekhethekileyo yokuvelisa kunye ne-6,000 yeemitha zesikwere se-ISO Class 8 yamagumbi okucoca abonelela ngesakhono esibalulekileyo sokukhula okuqhubekayo.Uninzi lweshishini langoku likaRitter ligxile ekukhonzeni ababoneleli benkqubo yokuxilonga kunye ne-OEM yokuphatha ulwelo.Ukufikeleleka kwejografi kunye nentengiso yejelo lehlabathi le-Avantor elikhokelayo kunye nokufikelela ngokunzulu kwabathengi kuya kuphucula ngokubonakalayo amandla ayo engeniso kwaye kubonelele ngamathuba abanzi emva kwentengiso.
"Ukuthengwa kweRitter kubonisa inyathelo elilandelayo kwinguqu eqhubekayo ye-Avantor," kusho uMichael Stubblefield, uMongameli kunye ne-CEO ye-Avantor."Ukudibanisa kuya kwandisa kakhulu ukunikezelwa kwethu kobunikazi kwi-biopharma kunye neemarike zokuphela kokhathalelo lwempilo kunye nokuphucula kakhulu iminikelo ye-Avantor ye-lab automation workflows ebalulekileyo. yeemveliso eziveliswe kumgangatho ochanekileyo ophakamisa isiphakamiso sexabiso lethu elikhethekileyo lomthengi."

"Le ntengiselwano ecetywayo inceda amaqela omabini, kunye nabathengi abakhoyo nabatsha," utshilo uJohannes von Stauffenberg, iCEO yeRitter."Ipotfoliyo ebanzi ye-Avantor isetyenziswe ngamawaka eenzululwazi kunye neebhubhoratri phantse kuzo zonke izigaba zezona zinto zibalulekileyo zophando, uphuhliso kunye nemisebenzi yokuvelisa. Siyavuya ngokudibanisa iimveliso zethu ezichanekileyo eziphezulu kunye nobuchule bokuvelisa ubugcisa kunye ne-Avantor yehlabathi jikelele. ukufikelela kunye nothando olunamandla lokufezekisa impumelelo yesayensi. "

Le ntengiselwano ikhulisa irekhodi eqinisekisiweyo ye-Avantor yempumelelo ye-M&A ngeentengiselwano ezinobungakanani ukusuka kwi-tuck-ins encinci ukuya enkulu, yeentengo zenguqu.Ukusukela ngo-2011, inkampani igqibe ngempumelelo iintengiselwano ezingama-40, yasebenzisa imali engaphezulu kwe-8 yeebhiliyoni zeedola kwaye yenza ngaphezulu kwe-350 yezigidi zeedola kwi-EBITDA synergies.

"Sijonge phambili ekongezeni amalungu eqela elinobuchule obuphezulu beRitter eJamani naseSlovenia kwintsapho yase-Avantor," wongezelela uMnu Stubblefield."Ngokufana ne-Avantor, i-Ritter isebenza ngokulawulwa kakhulu, izicelo eziqhutywe kwinkcazo kwaye ixhomekeke kwimodeli yokuvuselela intsebenziswano esekelwe kwintsebenziswano ukuze ikhonze abathengi bayo. Zombini iinkampani zabelana ngenkcubeko eyomeleleyo yezinto ezintsha kunye nokugqwesa, kunye nokuzinikela okucacileyo ekuzinzeni."

EzeMali kunye neeNkcukacha zokuvala
Intengiselwano kulindeleke ukuba yamkeleke ngokukhawuleza kwingeniso ehlengahlengisiweyo ngesabelo ngasinye (EPS) emva kokuvalwa kwaye kulindeleke ukuba ikhulise ukukhula kwengeniso ye-Avantor kunye neprofayili yomda.
I-Avantor ilindele ukuxhasa ngemali yonke intengiselwano ngekheshi ekhoyo kunye nokusetyenziswa kweemali-mboleko zexesha elongezelelweyo.Inkampani ilindele ukuba ulungelelwaniso olulungelelanisiweyo lwentsalela yomlinganiselo ekuvaleni iya kuba malunga ne-4.1x yetyala elishiyekileyo kwi-pro forma ye-LTM ehlengahlengisiweyo kwi-EBITDA, ngokukhawuleza ukugqithisela emva koko.
Intengiselwano ilindeleke ukuba igqitywe kwikota yesithathu ka-2021, kwaye ixhomekeke kwimiqathango yesintu, kubandakanywa nokwamkelwa kweemvume zolawulo ezisebenzayo.

Abacebisi
I-Jefferies LLC kunye ne-Centerview Partners LLC basebenza njengabacebisi bezezimali kwi-Avantor, kwaye i-Schilling, i-Zutt & Anschütz isebenza njengabacebisi bezomthetho.IGoldman Sachs Bank yaseYurophu SE kunye neCarlsquare GmbH basebenza njengabacebisi bezemali kwiRitter, kwaye uGleiss Lutz ukhonza njengomcebisi wezomthetho.Inkxaso-mali ezinikele ngokupheleleyo ekufumaneni ibonelelwe yiCitigroup Global Markets Inc.

Ukusetyenziswa kweMilinganiselo yezeMali engeyiyo ye-GAAP
Ukongeza kwimilinganiselo yemali elungiselelwe ngokwemigaqo yocwangciso-mali eyamkelwa ngokubanzi (GAAP), sisebenzisa imilinganiselo ethile engeyiyo eye-GAAP yezemali, kubandakanywa i-EPS ehlengahlengisiweyo kunye ne-EBITDA ehlengahlengisiweyo, engabandakanyi iindleko ezithile ezinxulumene-nokufunyanwa, kubandakanywa iintlawulo zokuthengisa uluhlu lwempahla oluhlaziyiweyo. ngomhla wokufumana kunye neendleko ezibalulekileyo zentengiselwano;uhlengahlengiso kunye nezinye iindleko/ingeniso;kunye nokuhlawula amatyala ee-asethi ezingaphathekiyo ezinxulumene nokufunyanwa.I-EPS ehlengahlengisiweyo ikwangabandakanyi ezinye iinzuzo kunye neelahleko ezibekwe zodwa okanye ezingenakulindelwa ukuba zenzeke kwakhona ngayo nayiphi na into eqhelekileyo okanye enokuxelwa kwangaphambili, amalungiselelo erhafu/izibonelelo ezinxulumene nezinto zangaphambili, izibonelelo ezivela kwintlawulo yetyala lerhafu, impembelelo yophicotho-zincwadi olubalulekileyo lwerhafu okanye iziganeko. kunye neziphumo zemisebenzi eyekiweyo.Asizibandakanyi ezi zinto zingasentla ngenxa yokuba zingaphandle kwemisebenzi yethu yesiqhelo kwaye/okanye, kwiimeko ezithile, kunzima ukuzixela kwangaphambili ngokuchanekileyo kwixesha elizayo.Sikholelwa ukuba ukusetyenziswa kwemilinganiselo engeyiyo eye-GAAP kunceda abatyali-zimali njengendlela eyongezelelweyo yokuhlalutya iintsingiselo ezisisiseko kwishishini lethu ngokungaguquguqukiyo kuwo onke amaxesha abonisiwe.Le milinganiselo isetyenziswa ngabaphathi bethu ngezizathu ezifanayo.Ulungelelwaniso lobungakanani be-EBITDA ehlengahlengisiweyo kunye ne-EPS ehlengahlengisiweyo kwingcaciso ye-GAAP ehambelanayo ayibonelelwanga ngenxa yokuba imilinganiselo ye-GAAP engabandakanyiyo inzima ukuqikelela kwaye ixhomekeke ngokuyintloko ekungaqinisekini kwexesha elizayo.Izinto ezinokungaqiniseki kwixesha elizayo zibandakanya ixesha kunye neendleko zemisebenzi yohlengahlengiso lwexesha elizayo, iintlawulo ezinxulumene nokurhoxa kwangoko kwetyala, utshintsho kumazinga erhafu kunye nezinye izinto ezingaphindi.

Umnxeba wekhonferensi
I-Avantor iya kubamba umnxeba wenkomfa ukuxoxa ngentengiselwano ngoMvulo, ngo-Aprili 12, 2021, ngo-8:00 am EDT.Ukuthatha inxaxheba ngefowuni, nceda ucofe (866) 211-4132 (yasekhaya) okanye (647) 689-6615 (yamazwe ngamazwe) kwaye usebenzise ikhowudi yenkomfa 8694890. Sikhuthaza abathathi-nxaxheba ukuba bajoyine imizuzu ye-15-20 kwangethuba ukugqiba inkqubo yokubhalisa.I-webcast ephilayo yomnxeba inokufumaneka kwicandelo labaTyali-mali kwiwebhusayithi yethu, www.avantorsciences.com.Ushicilelo lwentengiselwano kunye nezilayidi nazo ziya kuthunyelwa kwiwebhusayithi.Ukuphinda kuhlaziywe umnxeba kuya kufumaneka kwicandelo labaTyali-mali lewebhusayithi phantsi kwe "Iziganeko kunye neenkcazo" kude kube nge-12 kaMeyi, 2021.

Malunga neAvantor
I-Avantor®, inkampani ye-Fortune 500, ngumboneleli okhokelayo wehlabathi weemveliso ezibaluleke kakhulu kunye neenkonzo kubathengi kwi-biopharma, ukhathalelo lwempilo, imfundo kunye norhulumente, kunye nobuchwepheshe obuphambili kunye nemizi-mveliso yezixhobo ezisetyenzisiweyo.Ipotfoliyo yethu isetyenziswa phantse kuwo onke amanqanaba olona phando lubalulekileyo, uphuhliso kunye nemisebenzi yemveliso kumashishini esiwasebenzelayo.Umzila wethu wehlabathi jikelele usenza ukuba sikwazi ukukhonza iindawo zabathengi ezingaphezu kwama-225,000 kwaye usinika ukufikelela okubanzi kwiilebhu zophando kunye neenzululwazi kumazwe angaphezu kwe-180.Siye saqalisa inzululwazi ukwenza ihlabathi elingcono.Ngolunye ulwazi, nceda undwendwele www.avantorsciences.com.

Iingxelo ezijonge phambili
Olu shicilelo lweendaba luqulethe iingxelo ezijonge phambili.Zonke iinkcazo ngaphandle kweengxelo zeenyaniso zembali ezibandakanyiweyo kolu shicilelo lweendaba ziingxelo ezijonge phambili.Iingxelo ezijonge phambili zixoxa ngolindelo lwethu lwangoku kunye noqikelelo olunxulumene nentengiselwano yethu ebhengeziweyo neRitter kunye nemeko yethu yezemali, iziphumo zokusebenza, izicwangciso, iinjongo, ukusebenza kwekamva kunye neshishini.Ezi nkcazo zinokulandelwa, zilandelwe okanye zibandakanye amagama athi "injongo," "qikelela," "kholelwa," "qikelela," "lindela," "uqikelelo," "injongo," "inokwenzeka," "imbono," " isicwangciso," "inokwenzeka," "iprojekthi," "uqikelelo," "ukufuna," "inokuthi," "inokuthi," "inokuthi," "ifanele," "inokwenzeka," "iya," "intando," izichaso zayo kunye namanye amagama kunye amagama anentsingiselo efanayo.
Iingxelo ezijonge phambili ngokwendalo ziphantsi komngcipheko, ukungaqiniseki kunye nokucingelwa;azizoziqinisekiso zokusebenza.Akufunekanga uthembele ngokungafanelekanga kwezi nkcazo.Siseke ezi nkcazo ezijonge phambili kwizinto esizilindeleyo ngoku kunye noqikelelo malunga neziganeko ezizayo.Nangona sikholelwa ukuba uqikelelo lwethu olwenziwe ngokunxulumene neengxelo ezijonge phambili zinengqiqo, asinakuqinisekisa ukuba uqikelelo kunye nolindelo luya kungqineka luchanekile.Izinto ezinokuthi zibe negalelo kobu mngcipheko, ukungaqiniseki kunye nokucingela kubandakanya, kodwa kungaphelelanga apho, izinto ezichazwe "kwimiba yoMngcipheko" kwiNgxelo yethu yoNyaka ka-2020 kwiFomu ye-10-K yonyaka ophele nge-31 kaDisemba, 2020, ekwifayile. kunye ne-US Securities and Exchange Commission ("SEC") kwaye ifumaneka kwicandelo elithi "Investors" lewebhusayithi ye-Avantor, ir.avantorsciences.com, phantsi kwesihloko esithi "SEC Filings," kunye nakweyiphi na iNgxelo yekota elandelayo kwiFomu 10-Q kunye amanye amaxwebhu iifayile ze-Avantor kunye ne-SEC.
Zonke iingxelo ezijonge phambili eziya kuthi zenziwe kuthi okanye abantu abasimelayo bafaneleke ngokucacileyo ngokwezi ngxelo zilumkisayo.Ukongeza, zonke izitatimende ezijonge phambili zithetha kuphela ukusukela ngomhla wolu shicilelo lweendaba.Senza akukho zibophelelo ukuhlaziya okanye ukuhlaziya esidlangalaleni naziphi na iinkcazo ezijonge phambili, nokuba kungenxa yolwazi olutsha, iziganeko zexesha elizayo okanye ngenye indlela ngaphandle kokuba kufunwa phantsi kwemithetho yezokhuseleko.

0C6A3549
0C6A7454
0C6A7472

Ixesha lokuposa: Apr-21-2022